Brexit costs and red tape are denying British cancer patients life-saving drugs and trials of revolutionary treatments, a damning new report has warned. Soaring numbers are being diagnosed with cancer ...

Brexit readiness, regulatory science strategic planning, and medicine availability topped the list of big-picture areas of engagement between the European Medicines Agency (EMA) and industry ...

The House of Lords Industry and Regulators Committee published a 76 page report Thursday detailing “widespread concerns about the accountability of regulators” and suggesting the formation of a new ...

The London School of Economics (LSE) has suggested post-Brexit trade restrictions have accounted for a third of the food price increases seen in the UK since 2019. The UK voted to leave the European ...